The National Medical Products Administration (NMPA) has approved the OncoMate ® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China. It is ...
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma Promega MSI technology will aid in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results